Amylyx Pharmaceuticals reports stock sale
- George M. Jr Milne sold 30,000 shares on 10/05/2026
- Weighted average price was $27.6968
- Sale was under a 10b5-1 trading plan
George M Milne Jr, reporting
Every EDGAR filing for Amylyx Pharmaceuticals, Inc. (AMLX), newest first, with AI summaries and stories.
Next: earnings expected ~Nov 9 · 10-Q expected ~Nov 9 (deadline Nov 16)
No open-market insider buys in the last 30 days.
Also: 1 planned 10b5-1 sale ($831K).
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
George M Milne Jr, reporting
George M Milne Jr
Gina Mazzariello, insider filing for AMLX
Gina Mazzariello, reporting
Joshua B Cohen, planned sale of AMLX shares
Joshua B Cohen, reporting
Karen Firestone, insider filing for AMLX
Karen Firestone, reporting
Joshua B Cohen, insider filing for AMLX
Joshua B Cohen, reporting
Gina Mazzariello, insider filing for AMLX
Gina Mazzariello, reporting
Gina Mazzariello, planned sale of AMLX shares
Gina Mazzariello, reporting
Karen Firestone, insider filing for AMLX
Karen Firestone, reporting
Karen Firestone, insider filing for AMLX
Karen Firestone, reporting
Ownership stake disclosure by PERCEPTIVE ADVISORS LLC (amended)
PERCEPTIVE ADVISORS LLC, filed by
Ownership stake disclosure by VANGUARD GROUP INC (amended)
VANGUARD GROUP INC, filed by
Camille L Bedrosian, insider filing for AMLX
Camille L Bedrosian, reporting
Justin B. Klee, insider filing for AMLX
Justin B. Klee, reporting